Volkova, O.O., Shityakov, S.V. and Kravtsov, V.Y. 2023. Heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) as a pathogenetically significant drug target for oncology therapy (molecular docking of irinotecan and doxycycline). Patogenez (Pathogenesis). 21, 4 (Dec. 2023), 48-52. DOI:https://doi.org/10.25557/10.25557/2310-0435.2023.04.48–52.